RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+7.59%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.34B
AUM Growth
+$2.34B
(+6.2%)
Cap. Flow
+$80.4M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
23.61%
Holding
167
New
20
Increased
59
Reduced
15
Closed
19
Top Buys
| 1 |
AbbVie
ABBV
|
$56.8M |
| 2 |
Bristol-Myers Squibb
BMY
|
$38M |
| 3 |
HCA Healthcare
HCA
|
$36.9M |
| 4 |
Cencora
COR
|
$25.4M |
| 5 |
DaVita
DVA
|
$21.6M |
Top Sells
| 1 |
AAAP
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
|
$67.4M |
| 2 |
Cigna
CI
|
$65.2M |
| 3 |
Merck
MRK
|
$47.9M |
| 4 |
Johnson & Johnson
JNJ
|
$27.9M |
| 5 |
Willis Towers Watson
WTW
|
$18.5M |
Sector Composition
| 1 | Healthcare | 87.84% |
| 2 | Financials | 1.73% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
26
DELISTED
Celgene Corp
CELG
| $27.7M | 1.18% | 310,100 +7,100 | +2% | +$633K |
|
|
27
DaVita
DVA
$9.85B
| $26.9M | 1.15% | 407,500 +327,400 | +409% | +$21.6M |
|
28
Edwards Lifesciences
EW
$47.8B
| $26.5M | 1.13% | 190,001 | – | – |
|
|
WCG
29
DELISTED
Wellcare Health Plans, Inc.
WCG
| $25.9M | 1.11% | 134,000 | – | – |
|
|
30
Cencora
COR
$56.5B
| $25.4M | 1.08% | +295,000 | New | +$25.4M |
|
31
Thermo Fisher Scientific
TMO
$186B
| $23.6M | 1.01% | 114,500 +4,500 | +4% | +$929K |
|
32
Gilead Sciences
GILD
$140B
| $23.6M | 1.01% | 313,400 | – | – |
|
33
Teleflex
TFX
$5.59B
| $23.6M | 1.01% | 92,500 +750 | +0.8% | +$191K |
|
|
AVXS
34
DELISTED
AveXis, Inc. Common Stock
AVXS
| $23.5M | 1% | 190,000 +15,000 | +9% | +$1.85M |
|
|
MDCO
35
DELISTED
Medicines Co
MDCO
| $22.7M | 0.97% | 690,000 | – | – |
|
|
EPZM
36
DELISTED
Epizyme, Inc
EPZM
| $22.6M | 0.97% | 1,275,000 -50,000 | -4% | -$887K |
|
37
Assembly Biosciences
ASMB
$190M
| $21.8M | 0.93% | 443,000 -7,000 | -2% | -$344K |
|
38
Mersana Therapeutics
MRSN
$36.5M
| $20.5M | 0.87% | 1,300,000 -26,800 | -2% | -$423K |
|
|
WMGI
39
DELISTED
Wright Medical Group Inc
WMGI
| $19.8M | 0.85% | 1,000,000 +300,000 | +43% | +$5.95M |
|
|
ALDR
40
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $19.4M | 0.83% | 1,529,800 +474,800 | +45% | +$6.03M |
|
41
Baxter International
BAX
$12.7B
| $19.3M | 0.82% | 297,000 +67,000 | +29% | +$4.36M |
|
42
Sarepta Therapeutics
SRPT
$1.78B
| $19.1M | 0.82% | 258,000 | – | – |
|
43
Encompass Health
EHC
$12.3B
| $18.7M | 0.8% | 327,000 +62,000 | +23% | +$3.54M |
|
44
Jazz Pharmaceuticals
JAZZ
$7.75B
| $18.7M | 0.8% | 123,700 | – | – |
|
45
Insmed
INSM
$28.8B
| $18.6M | 0.79% | 825,000 +211,500 | +34% | +$4.76M |
|
46
Ascendis Pharma
ASND
$11.8B
| $18.5M | 0.79% | 283,500 +3,500 | +1% | +$229K |
|
47
Galapagos
GLPG
$2.07B
| $18.5M | 0.79% | 185,000 | – | – |
|
48
Axogen
AXGN
$743M
| $18.4M | 0.79% | 505,000 +27,500 | +6% | +$1M |
|
49
Alnylam Pharmaceuticals
ALNY
$58.5B
| $17M | 0.73% | 143,000 +13,000 | +10% | +$1.55M |
|
|
BOLD
50
DELISTED
Audentes Therapeutics, Inc
BOLD
| $17M | 0.72% | 565,000 +40,000 | +8% | +$1.2M |
|